Richard Paolone is a Toronto-based securities lawyer with extensive experience in corporate finance, securities law, and mergers and acquisitions. Mr. Paolone plays a key role in advising on a range ...

The Institute of Chemical Technology, Mumbai, in collaboration with the Mumbai Biocluster, successfully hosted the 5th Annual ...

Entero Therapeutics has named Richard Paolone as interim chief executive.

Quebec City-based company specialized in plant-based biomanufacturing of innovative vaccines, and the Biologics Manufacturing Centre (BMC), a non-for-profit organization dedicated to manufacturing ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Analysts at HC Wainwright issued their FY2029 earnings estimates for shares of Corbus Pharmaceuticals in a note issued to investors on Monday, February 10th. HC Wainwright analyst A. Maldonado expects ...

In conjunction with (i) the royalty financing deal with HealthCare Royalty (HCRx) announced on January 30, 2025, and (ii) the final terms of the dual proposal to the 2025 OCEANEs holders announced on ...

Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

Richard Gonzalez is retiring as chairman of AbbVie. "AbbVie Names CEO Robert Michael Chairman as Richard Gonzales Retires," at 8:20 a.m. ET, misspelled his name as Gonzales in the headline and article ...

EMERYVILLE, CA - Dynavax Technologies Corporation (NASDAQ:DVAX), a biopharmaceutical firm valued at $1.68 billion, has entered into a material definitive agreement with West Pharmaceutical Services ...

StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a hold rating on the stock. ObsEva Price ...